Clinical trials · Detroit, MI
Urothelial Carcinoma of the Renal Pelvis and Ureter clinical trials in Detroit
We’re tracking 8 recruiting urothelial carcinoma of the renal pelvis and ureter studies with a site in or near Detroit — including Phase 1, Phase 2, Phase 2/Phase 3 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Detroit
- NCT04879329RecruitingPhase 2
Study for HER2-positive bladder cancer after limited treatment
This Phase 2 trial tests disitamab vedotin alone or with pembrolizumab for urothelial (bladder/urinary tract) cancer that has HER2-positive tumors. It aims to shrink tumors and improve outcomes, including for people who have had limited prior treatment or specific prior drug exposures.
Detroit, MichiganAges 18 years+ - NCT05987241RecruitingPhase 2/Phase 3
Using a blood test to guide immunotherapy after bladder/kidney cancer surgery
This study tests whether a blood test that detects tumor DNA can help guide the use of immunotherapy (nivolumab with or without relatlimab) after surgery for urothelial cancer. The goal is to see if starting immunotherapy based on the blood test results can prevent the cancer from coming back.
Detroit, MichiganAges 18 years+ - NCT05176483RecruitingPhase 1
New drug combinations for advanced solid tumors
This trial tests a new drug called zanzalintinib, which may slow or shrink various types of advanced cancer. It is given together with other cancer treatments, and the study is looking at many different cancers including kidney, prostate, bladder, lung, liver, and more.
Detroit, MichiganAges 18 years+ - NCT07097142RecruitingPhase 3
Shorter radiation for bladder cancer with chemo
This trial tests if a shorter course of radiation therapy works as well as the usual longer course for people with bladder cancer who are also receiving standard chemotherapy. The goal is to see if shorter treatment can reduce side effects while still being effective.
Detroit, MichiganAges 18 years+ - NCT04628767RecruitingPhase 2/Phase 3
Durvalumab plus chemo before surgery for upper tract cancer
This trial tests whether adding an immunotherapy drug (durvalumab) to chemotherapy before surgery can improve outcomes for people with high-grade upper tract urothelial cancer. It compares different treatment approaches based on whether a patient can receive cisplatin chemotherapy.
Livonia, MichiganAges 18 years+ - NCT07630155Recruiting
Single-use digital scope for kidney cancer surveillance
This trial tests a new, disposable flexible camera (ureteroscope) to safely check for or monitor upper urinary tract cancer in an office setting without putting you to sleep. The goal is to see if patients can tolerate this procedure comfortably while awake.
Ann Arbor, MichiganAges 18 years+ - NCT06356155RecruitingPhase 2
Study of two drugs before surgery for upper tract cancer
This trial tests a combination of two drugs, enfortumab vedotin and pembrolizumab, given before surgery for upper tract urothelial cancer. The goal is to see if this treatment can shrink the tumor and improve outcomes for patients who are candidates for surgery.
Ann Arbor, MichiganAges 18 years+ - NCT05874921Recruiting
Registry for adults with UTUC treated with Jelmyto
This registry collects information about adults with upper tract urothelial cancer (UTUC) who received Jelmyto after it was approved. It helps doctors understand outcomes and real-world experience with Jelmyto.
Ann Arbor, MichiganAges 18 years+
Hear when a new Urothelial Carcinoma of the Renal Pelvis and Ureter trial opens near Detroit, MI
We’ll email you when one opens near Detroit, MI — at most once a week, no account needed, unsubscribe anytime.
Urothelial Carcinoma of the Renal Pelvis and Ureter trials in other cities
Where these studies are running near Detroit
Institutions with a site for the recruiting urothelial carcinoma of the renal pelvis and ureter studies listed above.
- University of Michigan · 5 studies
- Henry Ford Health · 3 studies
- Henry Ford Health System · 2 studies
- Henry Ford Macomb Hospital-Clinton Township · 2 studies
- Henry Ford Medical Center-Columbus · 2 studies
- Henry Ford West Bloomfield Hospital · 2 studies
- Henry Ford Wyandotte Hospital · 2 studies
- Trinity Health IHA Medical Group Hematology Oncology - Brighton · 2 studies
What taking part in a urothelial carcinoma of the renal pelvis and ureter study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting urothelial carcinoma of the renal pelvis and ureter studies in Michigan.
Common questions
- Are there urothelial carcinoma of the renal pelvis and ureter clinical trials near Detroit?
- Yes. We're currently tracking 8 recruiting urothelial carcinoma of the renal pelvis and ureter studies with a site near Detroit, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a urothelial carcinoma of the renal pelvis and ureter study near Detroit?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Detroit to take part?
- Not necessarily. These studies have a site near Detroit, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a urothelial carcinoma of the renal pelvis and ureter trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New urothelial carcinoma of the renal pelvis and ureter studies open near Detroit regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.